Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × Tamoxifen × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Carcinoma, Intraductal, Noninfiltrating 6 Breast Carcinoma In Situ 4 Neoplasms 3 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Inflammatory Breast Neoplasms 1 ERα+ Breast Cancer 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Fulvestrant 2 trastuzumab deruxtecan 1 ribociclib 1 exemestane 1 Tamoxifen 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04059484 2026-02-24

AMEERA-3

Sanofi

Phase 2 Terminated

367 enrolled 30 charts

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡